Literature DB >> 27044866

Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition.

Yueqin Yang1, Juw Won Park2, Thomas W Bebee1, Claude C Warzecha1, Yang Guo3, Xuequn Shang4, Yi Xing5, Russ P Carstens6.   

Abstract

The epithelial-to-mesenchymal transition (EMT) is an essential biological process during embryonic development that is also implicated in cancer metastasis. While the transcriptional regulation of EMT has been well studied, the role of alternative splicing (AS) regulation in EMT remains relatively uncharacterized. We previously showed that the epithelial cell-type-specific proteins epithelial splicing regulatory proteins 1 (ESRP1) and ESRP2 are important for the regulation of many AS events that are altered during EMT. However, the contributions of the ESRPs and other splicing regulators to the AS regulatory network in EMT require further investigation. Here, we used a robust in vitro EMT model to comprehensively characterize splicing switches during EMT in a temporal manner. These investigations revealed that the ESRPs are the major regulators of some but not all AS events during EMT. We determined that the splicing factor RBM47 is downregulated during EMT and also regulates numerous transcripts that switch splicing during EMT. We also determined that Quaking (QKI) broadly promotes mesenchymal splicing patterns. Our study highlights the broad role of posttranscriptional regulation during the EMT and the important role of combinatorial regulation by different splicing factors to fine tune gene expression programs during these physiological and developmental transitions.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27044866      PMCID: PMC4959312          DOI: 10.1128/MCB.00019-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

Review 1.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Deciphering the splicing code.

Authors:  Yoseph Barash; John A Calarco; Weijun Gao; Qun Pan; Xinchen Wang; Ofer Shai; Benjamin J Blencowe; Brendan J Frey
Journal:  Nature       Date:  2010-05-06       Impact factor: 49.962

3.  rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.

Authors:  Shihao Shen; Juw Won Park; Zhi-xiang Lu; Lan Lin; Michael D Henry; Ying Nian Wu; Qing Zhou; Yi Xing
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-05       Impact factor: 11.205

4.  Function of quaking in myelination: regulation of alternative splicing.

Authors:  Jiang I Wu; Robyn B Reed; Paula J Grabowski; Karen Artzt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

5.  Adducin is required for desmosomal cohesion in keratinocytes.

Authors:  Vera Rötzer; Andreas Breit; Jens Waschke; Volker Spindler
Journal:  J Biol Chem       Date:  2014-04-07       Impact factor: 5.157

6.  The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.

Authors:  Claude C Warzecha; Shihao Shen; Yi Xing; Russ P Carstens
Journal:  RNA Biol       Date:  2009-11-22       Impact factor: 4.652

7.  CEACAM1 isoforms with different cytoplasmic domains show different localization, organization and adhesive properties in polarized epithelial cells.

Authors:  Ulla Sundberg; Björn Obrink
Journal:  J Cell Sci       Date:  2002-03-15       Impact factor: 5.285

8.  Adducins regulate remodeling of apical junctions in human epithelial cells.

Authors:  Nayden G Naydenov; Andrei I Ivanov
Journal:  Mol Biol Cell       Date:  2010-09-01       Impact factor: 4.138

9.  An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.

Authors:  Irina M Shapiro; Albert W Cheng; Nicholas C Flytzanis; Michele Balsamo; John S Condeelis; Maja H Oktay; Christopher B Burge; Frank B Gertler
Journal:  PLoS Genet       Date:  2011-08-18       Impact factor: 5.917

10.  TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.

Authors:  K Horiguchi; K Sakamoto; D Koinuma; K Semba; A Inoue; S Inoue; H Fujii; A Yamaguchi; K Miyazawa; K Miyazono; M Saitoh
Journal:  Oncogene       Date:  2011-10-31       Impact factor: 9.867

View more
  50 in total

Review 1.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

2.  Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles.

Authors:  Gabriela D A Guardia; Bruna R Correa; Patricia Rosa Araujo; Mei Qiao; Suzanne Burns; Luiz O F Penalva; Pedro A F Galante
Journal:  NPJ Genom Med       Date:  2020-01-16       Impact factor: 8.617

3.  Single-Cell RNA Sequencing Reveals mRNA Splice Isoform Switching during Kidney Development.

Authors:  Yishay Wineberg; Tali Hana Bar-Lev; Anna Futorian; Nissim Ben-Haim; Leah Armon; Debby Ickowicz; Sarit Oriel; Efrat Bucris; Yishai Yehuda; Naomi Pode-Shakked; Shlomit Gilad; Sima Benjamin; Peter Hohenstein; Benjamin Dekel; Achia Urbach; Tomer Kalisky
Journal:  J Am Soc Nephrol       Date:  2020-07-10       Impact factor: 10.121

Review 4.  RNA regulons in cancer and inflammation.

Authors:  Laura Simone Bisogno; Jack Donald Keene
Journal:  Curr Opin Genet Dev       Date:  2017-11-22       Impact factor: 5.578

5.  RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition.

Authors:  Yong-Eun Kim; Minho Won; Sung-Gwon Lee; Chungoo Park; Chang-Hwa Song; Kee K Kim
Journal:  Oncogene       Date:  2019-07-29       Impact factor: 9.867

6.  Mutations in the Epithelial Cadherin-p120-Catenin Complex Cause Mendelian Non-Syndromic Cleft Lip with or without Cleft Palate.

Authors:  Liza L Cox; Timothy C Cox; Lina M Moreno Uribe; Ying Zhu; Chika T Richter; Nichole Nidey; Jennifer M Standley; Mei Deng; Elizabeth Blue; Jessica X Chong; Yueqin Yang; Russ P Carstens; Deepti Anand; Salil A Lachke; Joshua D Smith; Michael O Dorschner; Bruce Bedell; Edwin Kirk; Anne V Hing; Hanka Venselaar; Luz C Valencia-Ramirez; Michael J Bamshad; Ian A Glass; Jonathan A Cooper; Eric Haan; Deborah A Nickerson; Hans van Bokhoven; Huiqing Zhou; Katy N Krahn; Michael F Buckley; Jeffrey C Murray; Andrew C Lidral; Tony Roscioli
Journal:  Am J Hum Genet       Date:  2018-05-24       Impact factor: 11.025

7.  A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.

Authors:  Fernando J de Miguel; María J Pajares; Elena Martínez-Terroba; Daniel Ajona; Xabier Morales; Ravi D Sharma; Francisco J Pardo; Ana Rouzaut; Angel Rubio; Luis M Montuenga; Ruben Pio
Journal:  Mol Oncol       Date:  2016-08-09       Impact factor: 6.603

8.  Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease.

Authors:  Lan Lin; Juw Won Park; Shyam Ramachandran; Yida Zhang; Yu-Ting Tseng; Shihao Shen; Henry J Waldvogel; Maurice A Curtis; Richard L M Faull; Juan C Troncoso; Olga Pletnikova; Christopher A Ross; Beverly L Davidson; Yi Xing
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

9.  ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development.

Authors:  Alex M Rohacek; Thomas W Bebee; Richard K Tilton; Caleb M Radens; Chris McDermott-Roe; Natoya Peart; Maninder Kaur; Michael Zaykaner; Benjamin Cieply; Kiran Musunuru; Yoseph Barash; John A Germiller; Ian D Krantz; Russ P Carstens; Douglas J Epstein
Journal:  Dev Cell       Date:  2017-10-26       Impact factor: 12.270

10.  Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.

Authors:  Marat S Pavlyukov; Hai Yu; Soniya Bastola; Mutsuko Minata; Victoria O Shender; Yeri Lee; Suojun Zhang; Jia Wang; Svetlana Komarova; Jun Wang; Shinobu Yamaguchi; Heba Allah Alsheikh; Junfeng Shi; Dongquan Chen; Ahmed Mohyeldin; Sung-Hak Kim; Yong Jae Shin; Ksenia Anufrieva; Evgeniy G Evtushenko; Nadezhda V Antipova; Georgij P Arapidi; Vadim Govorun; Nikolay B Pestov; Mikhail I Shakhparonov; L James Lee; Do-Hyun Nam; Ichiro Nakano
Journal:  Cancer Cell       Date:  2018-06-21       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.